Cargando…

Heterogeneity in pharmacological treatment and outcomes in Crohn’s disease patients in Catalonia: a population-based observational study

BACKGROUND: Heterogeneity in the treatment of a disease is a marker of suboptimal quality of care. The aim of this study is to evaluate the heterogeneity in the treatment used and the outcomes for Crohn’s disease (CD) in Catalonia. METHODS: All patients with CD included in the Catalan Health Surveil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunet, Eduard, Vela, Emili, Melcarne, Luigi, Llovet, Laura-Patricia, Puy, Anna, Clèries, Montserrat, Pontes, Caridad, García-Iglesias, Pilar, Villòria, Albert, Kaplan, Gilaad G., Calvet, Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Gastroenterology & Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126589/ https://www.ncbi.nlm.nih.gov/pubmed/35499519 http://dx.doi.org/10.1080/07853890.2022.2069851

Ejemplares similares

Time Trends of Crohn’s Disease in Catalonia from 2011 to 2017. Increasing Use of Biologics Correlates with a Reduced Need for Surgery
por: Brunet, Eduard, et al.
Publicado: (2020)

Economic burden of cirrhosis in Catalonia: a population-based analysis
por: Miquel, Mireia, et al.
Publicado: (2018)

Non-pharmacological interventions to improve the patient experience of colonoscopy under moderate or no sedation: a systematic review protocol
por: Sue-Chue-Lam, Colin, et al.
Publicado: (2020)

Low-dose naltrexone for the induction of remission in patients with mild to moderate Crohn’s disease: protocol for the randomised, double-blinded, placebo-controlled, multicentre LDN Crohn study
por: Paulides, Emma, et al.
Publicado: (2022)

Acupuncture for Crohn’s disease: a protocol for systematic review and meta-analysis
por: Han, Qiang, et al.
Publicado: (2023)

The Crohn's disease: associated ATG16L1 variant and Salmonella invasion
por: Messer, Jeannette S, et al.
Publicado: (2013)

A novel role of prognostic nutritional index in predicting the effectiveness of infliximab in Crohn's disease
por: Peng, Ziheng, et al.
Publicado: (2023)

Predictors of necessity for endoscopic balloon dilatation in patients with Crohn’s disease-related small bowel stenosis
por: Hayashi, Yukie, et al.
Publicado: (2021)

Factors associated with poor compliance amongst hospitalized, predominantly adolescent pediatric Crohn’s disease patients
por: Cohen, Nathaniel A., et al.
Publicado: (2022)

Efficacy of biological drugs in short-duration versus long-duration inflammatory bowel disease: a protocol for a systematic review and an individual-patient level meta-analysis of randomised controlled trials
por: Ben-Horin, Shomron, et al.
Publicado: (2019)

Diagnostic value of the antiglycoprotein-2 antibody for Crohn’s disease: a PRISMA-compliant systematic review and meta-analysis
por: Deng, Chuiwen, et al.
Publicado: (2017)

Lengthening adalimumab dosing interval in quiescent Crohn’s disease patients: protocol for the pragmatic randomised non-inferiority LADI study
por: Smits, L J T, et al.
Publicado: (2020)

Prospective randomised controlled trial of adults with perianal fistulising Crohn’s disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol
por: Gu, Bonita, et al.
Publicado: (2021)

Life-event stress induced by the Great East Japan Earthquake was associated with relapse in ulcerative colitis but not Crohn's disease: a retrospective cohort study
por: Shiga, Hisashi, et al.
Publicado: (2013)

Test accuracy of drug and antibody assays for predicting response to antitumour necrosis factor treatment in Crohn’s disease: a systematic review and meta-analysis
por: Freeman, Karoline, et al.
Publicado: (2017)

Control Crohn Safe with episodic adalimumab monotherapy as first-line treatment study (CoCroS): study protocol for a randomised controlled trial
por: Janssen, Laura, et al.
Publicado: (2021)

PRedicting Outcomes For Crohn’s dIsease using a moLecular biomarkEr (PROFILE): protocol for a multicentre, randomised, biomarker-stratified trial
por: Parkes, Miles, et al.
Publicado: (2018)

Is disease activity associated with social support and psychological distress in Crohn’s disease patients? Results of a cross-sectional study in a Chinese hospital population
por: Huang, Mengting, et al.
Publicado: (2023)

Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial
por: Buhl, Sine Schnoor, et al.
Publicado: (2014)

Protocol for a multinational risk-stratified randomised controlled trial in paediatric Crohn’s disease: methotrexate versus azathioprine or adalimumab for maintaining remission in patients at low or high risk for aggressive disease course
por: Harris, Rachel E, et al.
Publicado: (2020)

Protocol for a double-blind, randomised, placebo-controlled pilot study for assessing the feasibility and efficacy of faecal microbiota transplant in a paediatric Crohn’s disease population: PediCRaFT Trial
por: Pai, Nikhil, et al.
Publicado: (2019)

Proactive infliximab optimisation using a pharmacokinetic dashboard versus standard of care in patients with Crohn’s disease: study protocol for a randomised, controlled, multicentre, open-label study (the OPTIMIZE trial)
por: Papamichael, Konstantinos, et al.
Publicado: (2022)

Non-pharmacological treatments for irritable bowel syndrome: study protocol of an umbrella review of systematic review and meta-analyses
por: Jin, Song, et al.
Publicado: (2019)

Changes in Treatment Patterns and Costs for Lung Cancer Have Not Resulted in Relevant Improvements in Survival: A Population-Based Observational Study in Catalonia
por: Guarga, Laura, et al.
Publicado: (2022)

Not Everything That Ulcerates Is Crohn's Disease
por: Afecto, Edgar, et al.
Publicado: (2022)

Effects of ileocolonic delivered vitamin B(2), B(3) and C (ColoVit) or the Groningen anti-inflammatory diet on disease course and microbiome of patients with Crohn’s disease (VITA-GrAID study): a protocol for a randomised and partially blinded trial
por: Otten, Antonius Timotheus, et al.
Publicado: (2023)

An Unusual Endoscopic Finding of Gastric Crohn's Disease
por: Garrido, Isabel, et al.
Publicado: (2021)

Small Bowel Stricture Mimicking Megacolon in a Patient with Crohn's Disease
por: Fernandes, Samuel Raimundo, et al.
Publicado: (2016)

Effects of COVID-19 confinement on the incidence and mortality of major osteoporotic fractures: an observational study in Catalonia, Spain
por: Surís, Xavier, et al.
Publicado: (2022)

Management, Survival, and Costs of Pancreatic Cancer: Population-Based Observational Study in Catalonia
por: Guarga, Laura, et al.
Publicado: (2023)

The NOTA study: non-operative treatment for acute appendicitis: prospective study on the efficacy and safety of antibiotic treatment (amoxicillin and clavulanic acid) in patients with right sided lower abdominal pain
por: Tugnoli, Gregorio, et al.
Publicado: (2011)

The European lactase persistence genotype determines the lactase persistence state and correlates with gastrointestinal symptoms in the Hispanic and Amerindian Chilean population: a case–control and population-based study
por: Morales, Eugenia, et al.
Publicado: (2011)

Viusid, a nutritional supplement, increases survival and reduces disease progression in HCV-related decompensated cirrhosis: a randomised and controlled trial
por: Vilar Gomez, Eduardo, et al.
Publicado: (2011)

Fall in peptic ulcer mortality associated with increased consultant input, prompt surgery and use of high dependency care identified through peer-review audit
por: Aga, Hiba, et al.
Publicado: (2012)

Thirty-day mortality after elective and emergency total colectomy in Danish patients with inflammatory bowel disease: a population-based nationwide cohort study
por: Tøttrup, Anders, et al.
Publicado: (2012)

Characteristics of randomised trials on diseases in the digestive system registered in ClinicalTrials.gov: a retrospective analysis
por: Wildt, Signe, et al.
Publicado: (2011)

Retrospective study of patients with acute pancreatitis: is serum amylase still required?
por: Gomez, Dhanwant, et al.
Publicado: (2012)

Barriers and facilitators to change in the organisation and delivery of endoscopy services in England and Wales: a focus group study
por: Rapport, Frances, et al.
Publicado: (2012)

Liraglutide efficacy and action in non-alcoholic steatohepatitis (LEAN): study protocol for a phase II multicentre, double-blinded, randomised, controlled trial
por: Armstrong, Matthew J, et al.
Publicado: (2013)

Corticosteroids and risk of gastrointestinal bleeding: a systematic review and meta-analysis
por: Narum, Sigrid, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_os1qrsjje2hnm9u3ms7dkj3i22